CIARDULLO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 2.375
EU - Europa 1.583
AS - Asia 474
SA - Sud America 11
OC - Oceania 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.451
Nazione #
US - Stati Uniti d'America 2.328
IT - Italia 444
DE - Germania 299
IE - Irlanda 256
RU - Federazione Russa 196
SE - Svezia 178
CN - Cina 135
HK - Hong Kong 132
SG - Singapore 89
GB - Regno Unito 88
CA - Canada 47
IN - India 32
VN - Vietnam 32
FI - Finlandia 28
TR - Turchia 17
ID - Indonesia 15
UA - Ucraina 14
BE - Belgio 13
FR - Francia 13
DK - Danimarca 11
NL - Olanda 10
BR - Brasile 7
JP - Giappone 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
AU - Australia 5
IR - Iran 5
RO - Romania 5
PL - Polonia 4
PT - Portogallo 4
CO - Colombia 3
SA - Arabia Saudita 3
AT - Austria 2
NG - Nigeria 2
NO - Norvegia 2
TW - Taiwan 2
BN - Brunei Darussalam 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
JE - Jersey 1
MD - Moldavia 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
TH - Thailandia 1
Totale 4.451
Città #
Ann Arbor 702
Frankfurt am Main 253
Dublin 247
Chandler 201
Fairfield 175
Milan 131
Hong Kong 128
New York 128
Wilmington 99
Princeton 96
Ashburn 87
Chicago 86
Woodbridge 70
Cambridge 67
Seattle 63
Houston 60
Altamura 58
Singapore 57
London 48
Lawrence 47
Beijing 40
San Diego 36
Shanghai 36
Boardman 28
Dong Ket 24
Helsinki 21
Jakarta 15
Kocaeli 15
Toronto 14
Brussels 13
Guangzhou 12
Monza 12
Nanjing 12
Rome 12
Carate Brianza 11
Dearborn 11
Andover 10
Pune 10
Capurso 9
Norwalk 9
Sacramento 9
Hyderabad 8
Lappeenranta 7
Esslingen am Neckar 6
Bergamo 5
Brno 5
Falls Church 5
Floridia 5
Los Angeles 5
San Mateo 5
São Paulo 5
Abbadia Lariana 4
Bari 4
Cascina 4
Hangzhou 4
Kilburn 4
Munich 4
New Delhi 4
Palermo 4
Raleigh 4
Redmond 4
Segrate 4
Southwark 4
Torino 4
Washington 4
Amsterdam 3
Cinisello Balsamo 3
Council Bluffs 3
Ergolding 3
Fremont 3
Fukuyama 3
Groningen 3
Gunzenhausen 3
Jacksonville 3
Jalandhar 3
Kardzhali 3
Laurel 3
Leawood 3
Legnano 3
Lissone 3
Magenta 3
Mistretta 3
Novara 3
Riyadh 3
Trumbull 3
Wenzhou 3
Americana 2
Assago 2
Bangalore 2
Baranzate 2
Berlin 2
Bogotá 2
Burgas 2
Camaiore 2
Cefalù 2
Cinisello 2
Cornate d'Adda 2
Dallas 2
Dongguan 2
Edmonton 2
Totale 3.365
Nome #
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? 329
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 163
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 156
Endocrinology and Metabolic Diseases (Including Diabetes) 152
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 151
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes 139
Lack of awareness of liver organ damage in patients with type 2 diabetes 108
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes 103
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 100
Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications 96
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population 92
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 91
Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016 86
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey 83
Risk stratification tools for heart failure in the diabetes clinic 80
Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery 80
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 80
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 79
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories 76
Metabolic and psychological features are associated with weight loss 12 months after sleeve gastrectomy 75
Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease 71
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 70
An unexpected bilateral mass after total thyroidectomy 70
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes 68
Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population 67
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 67
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study 67
Comment on “An Observational Data Meta-Analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD” 65
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents 65
NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population 63
Exploring the landscape of steatotic liver disease in the general US population 62
Impact of the duration of type 2 diabetes on the screening for nonal- coholic fatty liver disease and advanced fibrosis 62
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy 61
Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. women 61
Setting up of a machine learning algorithm for the identification of severe liver fibrosis profile in the general US population cohort 60
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 60
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 59
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 56
Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: A retrospective cohort study 54
Reply [to: Use of FibroScan–AST Score to Stratify High-Risk Nonalcoholic Steatohepatitis in US...] 52
Non-invasive scores of liver fibrosis in morbidly obese patients 52
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes and association with micro- and macrovascular complications 49
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting 49
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population 48
Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population 46
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis 46
Twenty-year trends in heart failure among U.S. adults, 1999–2018: The growing impact of obesity and diabetes 44
Sex-related association of NAFLD and liver fibrosis with body fat distribution in the general US population 41
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population 40
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients 40
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 39
Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States 37
Advances in fibrosis biomarkers in nonalcoholic fatty liver disease 37
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 36
Global multi-stakeholder endorsement of the MAFLD definition 35
Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study 34
Control of Blood Glucose and Cardiovascular Risk Profile 33
Authors' reply to Shang et al. 30
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 30
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 30
Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes 29
Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD 28
Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition 26
Authors' reply to Zou et al 26
Trends in prevalence of probable fibrotic nonalcoholic steatohepatitis in the United States, 1999-2016 23
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study 22
Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis 22
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment 20
Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment 20
Liver stiffness is associated with all-cause mortality in patients with NAFLD: A systematic review and meta-analysis 20
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 19
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States 17
Serum neurofilament light chain levels are associated with all-cause mortality in the general US population 17
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study 16
Silent threats: how NAFLD and hypertension team up in young adults, and the role of sex 15
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 14
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 13
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 9
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes 9
Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence 9
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus 9
The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner? 7
Totale 4.765
Categoria #
all - tutte 25.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020230 0 1 30 18 16 17 14 22 29 34 31 18
2020/2021998 16 30 45 65 72 70 85 116 133 144 88 134
2021/2022741 117 88 99 42 25 52 28 35 50 62 44 99
2022/20231.240 146 226 123 108 92 228 40 71 87 26 58 35
2023/20241.236 89 42 84 102 112 216 166 53 91 53 34 194
2024/2025299 215 84 0 0 0 0 0 0 0 0 0 0
Totale 4.765